This inventor holds 1 USPTO granted patent. Top assignee: Chimera Bioengineering, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eytan Herzig: Innovator in CAR T-cell Therapy
Introduction
Eytan Herzig is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of advanced therapies for cancer treatment. His innovative work focuses on enhancing the efficacy of CAR T-cell therapies.
Latest Patents
Eytan holds a patent for "Compositions and Methods for Anti-TnMUC1 Gold CAR T-cells." This patent represents a breakthrough in the application of CAR T-cell technology, aiming to improve the targeting and destruction of cancer cells.
Career Highlights
Eytan is currently employed at Chimera Bioengineering, Inc., where he continues to push the boundaries of cancer research and therapy. His work is instrumental in developing novel approaches to immunotherapy, which have the potential to save countless lives.
Collaborations
Eytan collaborates with talented individuals such as Benjamin Wang and Gusti Zeiner. Together, they work on innovative projects that aim to revolutionize cancer treatment through cutting-edge technology.
Conclusion
Eytan Herzig is a key figure in the field of CAR T-cell therapy, with a focus on developing effective treatments for cancer. His contributions and collaborations are paving the way for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile